Immediate Restoration of Disc Height and Lordosis With PROLIFT® Expandable Spacer System

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Life Spine announced today that the Company has published a new white paper examining the immediate restoration of patient disc height, foraminal height and lordosis with the PROLIFT Expandable Spacer System. This white paper is one of many papers and studies that Life Spine will be releasing over the next few years.

The paper assessed the results of patients who had undergone one or two-level TLIFs with the PROLIFT System across four separate sites. The objective of the paper was to see how the benefits of the PROLIFT System affected immediate patient results. Some benefits of the PROLIFT System are facilitated insertion through collapsed initial height, in-situ expansion to optimize endplate contact and restoration of disc height.

Top takeaways from the paper include an average focal lordotic correction of over 5°, average disc height correction of nearly 4mm and average restoration of foraminal height of about 4mm. The study found that use of the PROLIFT expandable interbody device for open and MIS TLIF procedures resulted in superior results and lower subsidence rates to those of static devices reported in published literature.

“Since launching the system we have received excellent feedback and results from our surgeon users in case reports, so it was important for us to log more substantial clinical data against traditional interbody devices to see just how well PROLIFT performs. The results are outstanding and I am looking forward to the results of our full PROLIFT clinical study,” said Mariusz Knap, Sr. VP of Business Development & Marketing for Life Spine.

Life Spine a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.